These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2860681)

  • 1. Biological factors in obsessive-compulsive disorders.
    Turner SM; Beidel DC; Nathan RS
    Psychol Bull; 1985 May; 97(3):430-50. PubMed ID: 2860681
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of drug therapy in the treatment of obsessive-compulsive disorders].
    Teeuwisse JM; Nolen WA
    Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2605-8. PubMed ID: 2575230
    [No Abstract]   [Full Text] [Related]  

  • 3. Obsessive-compulsive disorder: a treatment review.
    Perse T
    J Clin Psychiatry; 1988 Feb; 49(2):48-55. PubMed ID: 2892831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of obsessive-compulsive disorders.
    Murray JB
    Genet Soc Gen Psychol Monogr; 1986 May; 112(2):173-99. PubMed ID: 2875011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle latency evoked potentials in obsessive-compulsive disorder.
    Khanna S; Mukundan CR; Channabasavanna SM
    Biol Psychiatry; 1989 Apr; 25(7):980-3. PubMed ID: 2720012
    [No Abstract]   [Full Text] [Related]  

  • 6. Obsessional states.
    Pollitt J
    Br J Psychiatry; 1975; Spec No 9():133-40. PubMed ID: 241447
    [No Abstract]   [Full Text] [Related]  

  • 7. Obsessive-compulsive disorders: a review of the literature.
    Salzman L; Thaler FH
    Am J Psychiatry; 1981 Mar; 138(3):286-96. PubMed ID: 6110343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychophysiological and clinical value of event-related potentials in obsessive-compulsive disorder.
    Morault PM; Bourgeois M; Laville J; Bensch C; Paty J
    Biol Psychiatry; 1997 Jul; 42(1):46-56. PubMed ID: 9193741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacologic treatment of refractory pediatric obsessive compulsive disorder.
    Ferren T; Palmes GK; Kaplan SG
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):509-12. PubMed ID: 24024535
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic treatment of anxiety disorders.
    Mavissakalian M
    J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance monitoring in obsessive-compulsive disorder.
    Nieuwenhuis S; Nielen MM; Mol N; Hajcak G; Veltman DJ
    Psychiatry Res; 2005 Apr; 134(2):111-22. PubMed ID: 15840412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polygraphic study o the phases, cycles and reactivity in sleep in neurotic subjects].
    Angeleri F; Bergonzi P; Ferroni A
    Riv Neurol; 1968; 38(2):120-32. PubMed ID: 5660786
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracerebral potentials in humans evoked by expectancies of peripheral stimuli.
    Weinberg H; Walter WG; Crow HJ
    Electroencephalogr Clin Neurophysiol; 1970 Apr; 28(4):424-5. PubMed ID: 4191219
    [No Abstract]   [Full Text] [Related]  

  • 15. [Schizophrenia and obsessive-compulsive disorder--some considerations based on a case].
    Sümeg S; Herold R; Tényi T
    Psychiatr Hung; 2005; 20(1):35-9. PubMed ID: 16389732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroendocrine disturbances observed in obsessive compulsive disorders].
    Hantouche E; Olié JP
    Ann Med Psychol (Paris); 1992; 150(2-3):152-7. PubMed ID: 1343510
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of comorbid anxiety and depression.
    Zajecka JM; Ross JS
    J Clin Psychiatry; 1995; 56 Suppl 2():10-3. PubMed ID: 7844101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug treatment of sleep disorders].
    Lund R; Rüther E
    Internist (Berl); 1984 Sep; 25(9):543-6. PubMed ID: 6149199
    [No Abstract]   [Full Text] [Related]  

  • 20. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.